When your ability to methylate is decreased, the mutation has a greater potential to impact your health
GLP-1 agonists are increasingly used early in type 2 diabetes management, particularly when weight loss is a treatment goal or when cardiovascular risk is high
Greig NH, Holloway HW, de Ore KA, Jani D, Wang Y, Zhou J, et al
When it comes to individuals with severe obesity or obesity-related health issues, as well as those with 50+ pounds to lose, surgery continues to yield superior results over all non-surgical methods
This attention has highlighted how much more is needed to address the global obesity epidemic: a greater understanding of the disease, a broader focus on the diversity of the patient population, and most of all, the great need for new therapeutic classes that can benefit the many underserved patients living with obesity
HMB has some support in older adults and during severe deficits, but it does not replace creatine